◆ A&T& = Appointment of CEO Park Raesung


◆ EQCell = Decision to raise 7.5 billion KRW through a paid-in capital increase to secure operating funds and debt repayment funds


◆ ST Pharm = Supply contract for new drug active pharmaceutical ingredients worth 32.2 billion KRW with a Europe-based global pharmaceutical company



◆ U-Tech = Decision to raise 5 billion KRW through a paid-in capital increase to secure operating funds


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing